Why the study?
Does prostaglandin E1 reduce myocardial reperfusion injury and alter cytokine balance in patients undergoing cardiac surgery on cardiopulmonary bypass?
Does prostaglandin E1 reduce myocardial reperfusion injury and alter cytokine balance in patients undergoing cardiac surgery on cardiopulmonary bypass?
Prostaglandin E1 administration during cardiac surgery reduces myocardial reperfusion injury and suppresses proinflammatory cytokines IL-6 and IL-8.
Answers are grounded in this paper and cite their sources.
May support PGE1 use to limit reperfusion injury in CPB surgery; extends cytokine modulation evidence to cardiac procedures.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kawamura et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: